Treatment with HA-NPs in DIO mice reduced eWAT mass through suppression of adipogenesis and lipogenesis as indicated by decreased adipogenic and lipogenic regulators, while these effects were not observed in CD44−/− mice, suggesting a potential anti-obesity strategy targeting CD44 by HA-NPs. The gene discussed is CD44; the disease is obesity due to melanocortin 4 receptor deficiency.